Subtype
Ovarian Neoplasm
CI-CAN-00001335Explore in graph →
Non-malignant746 active trials5 approved drugs94 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001335Explore in graph →
Clinical trials
3,430 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01779128 | PET-CT vs. Integrated MR-PET Scanning of GYN Cancers | unknown | Early Phase 1 | 100 | Massachusetts General HospitalOTHER | 1 | Jan 30, 2013 | clinicaltrials |
| NCT00436410 | Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer | completed | Early Phase 1 | 108 | National Institutes of Health Clinical Center (CC)NIH | 1 | May 2, 2012 | clinicaltrials |
| NCT00253461 | 11C Topotecan PET Imaging | terminated | Early Phase 1 | 7 | Case Comprehensive Cancer CenterOTHER | 1 | Mar 20, 2012 | clinicaltrials |
| NCT00620243 | Pilot Study to Evaluate 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography /Computed Tomography (PET/CT) in Prediction of Early Response to Chemotherapy in Ovarian Cancer. | completed | Early Phase 1 | 9 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 9, 2012 | clinicaltrials |
Data updated 22 days agoSource updated Jan 30, 2013source: clinicaltrials